erlotinib hydrochloride has been researched along with Corneal Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kau, HC; Tsai, CC | 1 |
| Chu, DS; Johnson, KS; Levin, F | 1 |
| Ashizawa, J; Deguchi, Y; Hashimoto, R; Hitani, K; Hori, Y; Maeno, T; Shiba, T; Ubuka, M | 1 |
3 other study(ies) available for erlotinib hydrochloride and Corneal Diseases
| Article | Year |
|---|---|
Erlotinib-related keratopathy in a patient underwent laser in situ keratomileusis.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Bone Neoplasms; Corneal Diseases; ErbB Receptors; Erlotinib Hydrochloride; Humans; Keratomileusis, Laser In Situ; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Spinal Neoplasms | 2016 |
Persistent corneal epithelial defect associated with erlotinib treatment.
Topics: Aged; Cataract Extraction; Corneal Diseases; Epithelium, Corneal; Erlotinib Hydrochloride; Female; Humans; Keratitis; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines; Staphylococcal Infections; Staphylococcus epidermidis | 2009 |
[A case of a corneal disorder after lung cancer treatment with erlotinib].
Topics: Corneal Diseases; ErbB Receptors; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Middle Aged; Quinazolines | 2012 |